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Abstract 27 
Glutaraldehyde is one of most widely used reagents in the design of biocatalysts. It is a 28 
powerful crosslinker, able to react with itself, with the advantages that this may bring forth. In 29 
this review, we intend to give a general vision of its potential and the precautions that must be 30 
taken when using this effective reagent. First, the chemistry of the glutaraldehyde/amino 31 
reaction will be commented. This reaction is still not fully clarified, but it seems to be based on 32 
the formation of 6-membered heterocycles formed by 5 C and one O. Then, we will discuss the 33 
production of intra and inter-molecular enzyme crosslinkings (increasing enzyme rigidity or 34 
preventing subunit dissociation in multimeric enzymes). Special emphasis will be placed on the 35 
preparation of cross-linked enzyme aggregates (CLEAs), mainly in enzymes that have low 36 
density of surface reactive groups and, therefore, may be problematic to obtain a final solid 37 
support. Next, we will comment on the uses of glutaraldehyde in enzymes previously 38 
immobilized on supports. First, the treatment of enzymes immobilized on supports that cannot 39 
react with glutaraldehyde (only inter and intramolecular cross-linkings will be possible) to 40 
prevent enzyme leakage and obtain some enzyme stabilization via cross-linking. Second, the 41 
cross-linking of enzymes adsorbed on aminated supports, where together with other reactions 42 
enzyme/support crosslinking is also possible; the enzyme is incorporated to the support. Finally, 43 
we will present the use of aminated supports preactivated with glutaraldehyde. Optimal 44 
glutaraldehyde modifications will be discussed in each specific case (one or two glutaraldehyde 45 
molecules for amino group in the support and/or the protein). Using preactivated supports, the 46 
heterofunctional nature of the supports will be highlighted, with the drawbacks and advantages 47 
that the heterofunctionality may have. Particular attention will be paid to the control of the first 48 
event that causes the immobilization depending on the experimental conditions to alter the 49 
enzyme orientation regarding the support surface. Thus, glutaraldehyde, an apparently old 50 
fashioned reactive, remains as the most widely used and with broadest application possibilities 51 
among the compounds used for the design of biocatalyst. 52 
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1. Introduction 56 
 Enzymes are biocatalysts which catalyze most metabolic reactions in living beings. In 57 
vivo, they are highly specific (modifying just one substrate among a collection of similar ones), 58 
chemo/enantio/regio-selective (yielding just one substrate among several possible) and very 59 
active under very mild environmental conditions (atmospheric pressure, room temperature, 60 
aqueous medium). Thus, enzymes have been considered the ideal catalyst from an 61 
environmental point of view, in reactions involving complex or labile compounds.1-5  62 
 However, enzymes perform their function inside living beings, under complex 63 
regulations and stress. This causes enzymes to become inhibited by many compounds. Thus, 64 
their in vivo stability can hardly be measured in days, and their exceptional properties may not 65 
be found when they are utilized for modifying other substrates (different to the physiological 66 
ones) or even performing other reactions (e.g., using hydrolases as transferases in kinetically 67 
controlled synthesis). Moreover, the soluble nature of the enzymes avoids their extended use 68 
(and subsequent re-use) in industry. These properties are far from the requirements of an 69 
industrial catalyst.6  70 
 The solution to these limitations is the main subject of enzyme technology. The 71 
researcher may use a handful of different tools, such as microbiology,2 genetic approaches,7-10 72 
immobilization,11-17 chemical modification,18,19 and medium and reactor engineering to shortcut 73 
these enzyme limitations. Many of these tools may be used in an integrated way.20-23  74 
 Physicochemical tools, such as chemical modification or enzyme immobilization, have 75 
special interest in this context. Due to the requirements of producing a heterogeneous catalyst, 76 
enzyme immobilization becomes a necessity from this perspective.14 This strategy has been 77 
investigated by many authors as a way to improve enzyme properties. It has been shown that 78 
enzyme stability may be significantly improved if an intense multipoint covalent attachment 79 
(MCA) between an enzyme molecule and a rigid support, via a short spacer arm, is achieved.17  80 
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This phenomenon causes all groups involved in the immobilization to keep their relative 81 
positions when the enzyme is submitted to any conformational change. The area of the enzyme 82 
involved in the immobilization may be also critical to maximize the stabilizing effect of the 83 
MCA.22 Immobilization may also tune some other enzyme properties, such as activity, 84 
resistance to inhibition, selectivity or specificity.17 Chemical modification of enzymes may be 85 
used to further improve enzyme stability (e.g., via chemical crosslinking),24 and may be also 86 
used as another tool to alter enzyme catalytic features.18 Moreover, as it has been revised, 87 
chemical modification or immobilization of enzymes may be designed to simplify or improve 88 
one another.21   89 
 Glutaraldehyde is the reagent that the present review is devoted to. It has been used in 90 
many instances as protein cross-linker, as an activator of supports, and as crosslinker of enzymes 91 
and supports.25,26 In this review, we intend to give a wide vision of the prospects of this very 92 
interesting and versatile molecule in the design of biocatalysts. 93 
 94 
2. Chemistry of glutaraldehyde 95 
 Glutaraldehyde is a bi-functional reagent with the capacity to polymerize.27,28 96 
Glutaraldehyde may react with different enzyme moieties, mainly involving primary amino 97 
groups of proteins, although it may eventually react with other groups (thiols, phenols, and 98 
imidazoles).27-30 However, the exact structure of the main structures related to protein 99 
crosslinking or enzyme immobilization is still not fully clarified. Figure 1 shows some of these 100 
proposed structures. It is clear that the structure of the glutaraldehyde relevant for the 101 
modification of enzymes and supports is not a linear one, but some kind of fairly stable cycles 102 
(activated support may be washed with an excess of distilled water without losing 103 
glutaraldehyde moieties). 104 
 105 
 106 
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The reaction mechanism of glutaraldehyde with proteins implies that it is not limited to just one 107 
mechanism. This is because the main reactive species of glutaraldehyde are found in equilibrium 108 
between their monomeric and polymeric conformations.27,28,31,32 Moreover, every structure can 109 
react in a different way with the protein. For instance, under both acidic and neutral conditions, 110 
aldehyde groups from glutaraldehyde can react with proteins by formation of Schiff bases. In 111 
this case, a nucleophilic attack takes place by the ε-amino group from lysine to glutaraldehyde 112 
(See Figure 2a). However, Schiff bases are unstable at acidic conditions and are broken up, 113 
regenerating both the aldehyde and the amine groups. For this reason, several procedures have 114 
recommended reduction by NaBH4 or NaBCNH3 as a final step in order to stabilize the Schiff 115 
base into a secondary amine. Nevertheless, some studies suggest that protein preparations 116 
treated with a reducing agents does not cause an striking increase in the enzyme stability.33 117 
Additionally, lysine residues of protein treated with glutaraldehyde without further chemical 118 
reduction are not regenerated by incubation in HCl 6M at 110 ºC by 24 h.34 Consequently, it is 119 
possible that a mechanism of formation of Schiff bases between proteins and glutaraldehyde 120 
could not be carried out. In this sense, an additional reduction step would not be necessary in 121 
order to stabilize the reaction product.27,28,35 Therefore, the mechanism of glutaraldehyde at 122 
neutral and acidic conditions would be mediated by hemiacetal cyclic conformations from both 123 
the monomer and polymer of glutaraldehyde. This cyclic hemiacetal of glutaraldehyde reacts by 124 
nucleophilic substitution of the amino groups from lysines with the hydroxy group of 125 
glutaraldehyde according to the Figure 2.  126 
On the other hand, under basic conditions it has been proposed that glutaraldehyde quickly 127 
suffers intramolecular aldolic condensations, producing a polymeric form of an a α,β-128 
unsaturated aldehyde, which may react with amino groups from proteins through two 129 
mechanisms: Firstly by formation of Schiff bases between internal aldehyde groups from the 130 
polymeric form of glutaraldehyde and primary amino groups from the protein (Figure 3, 131 
reaction 1). In this case, the obtained product could be stabilized by a resonance effect of 132 
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conjugated double C-C bonds.32 The second mechanism involves a Michael addition to the 133 
double C-C linkage.27 However, this reaction results in a less stable product due to loss of 134 
resonance effect of the conjugated double C-C bonds, which would be labile under acidic 135 
conditions (Figure 3,). 136 
 Prof. Monsan,36,37 has shown that it is relatively simple to only have one or two 137 
molecules of glutaraldehyde per amino group in a support. This result, coupled to some more 138 
recent ones that confirm this, suggested a different reactivity of the amino/glutaraldehyde 139 
moiety with free glutaraldehyde compared to the capacity of free glutaraldehyde molecule to 140 
polymerize, as under the described conditions to get this amino/glutaraldehyde/glutaraldehyde 141 
moiety there is not a massive precipitation of glutaraldehyde polymers.38 Amino/glutaraldehyde 142 
reacted with free glutaraldehyde much more rapidly that free glutaraldehyde with free 143 
glutaraldehyde molecules. It also showed that the two glutaraldehyde molecules/amino moiety 144 
groups in the support possessed the structure that exhibited the highest reactivity versus amino 145 
groups in a protein. If just one glutaraldehyde molecule was attached to the amino group, this 146 
moiety exhibited a low reactivity versus amino groups. However, this group, together with the 147 
already commented reactivity versus free glutaraldehyde molecules, exhibited a vey high 148 
reactivity versus other similar amino/glutaraldehyde moieties, being the activation of a protein 149 
the preferred way to get crosslinkings as we will discuss later. This different reactivity of the 150 
amino/glutaraldehyde moiety compared to the glutaraldehyde or the 151 
amino/glutaraldehyde/glutaraldehyde moiety should be found in the presence of an amino group 152 
in the heterocycle of the glutaraldehyde ring.39,40 Amino/glutaraldehyde/glutaraldehyde has a 153 
similar reactivity when compared to free glutaraldehyde, as the second glutaraldehyde group 154 
will be very similar to free glutaraldehyde. If the conditions were forced (e.g., increasing the pH 155 
value or the glutaraldehyde concentration) to get a higher degree of polymerization on the amino 156 
group, the free glutaraldehyde may also react; giving large glutaraldehyde aggregates that may 157 
precipitate and the suspension will turn white. 158 
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3. Glutaraldehyde as protein crosslinker 160 
 The first use of glutaraldehyde was to preserve and fix tissues41,42 in some instances 161 
combined with formaldehyde.25 This is achieved through the formation of intermolecular 162 
crosslinking. Nowadays, glutaraldehyde remains as one of the most potent crosslinker reagents, 163 
even with clinical applications.43-45 In part, these very good crosslinker features are a 164 
consequence of the capacity of glutaraldehyde to react with itself or with protein groups already 165 
modified with a glutaraldehyde molecule.28  166 
 The protein crosslinkings may be among groups placed on different protein molecules 167 
(intermolecular crosslinking) or between groups placed in the same molecule (intramolecular 168 
crosslinkings).24,46 Both kinds of crosslinkings have interest in specific cases. 169 
 170 
3.1- Glutaraldehyde as intermolecular crosslinker of proteins 171 
 As previously commented, this was the first use of glutaraldehyde, using its crosslinker 172 
potential to fix tissues.41 However, in this review we will focus on the use of glutaraldehyde in 173 
the design of biocatalysts.  174 
 The addition of glutaraldehyde to a protein solution may produce the chemical 175 
aggregation of the enzyme, causing protein molecules to react among themselves, and can 176 
directly yield a “solid biocatalyst” (Figure 4). Although this immobilization strategy has not 177 
been widely used, it is possible to find diverse examples in literature. For example, insoluble 178 
trypsin was prepared by the use of glutaraldehyde to produce intermolecular crosslinks and the 179 
insoluble trypsin thus prepared exhibited enzymatic activity toward casein.47 Later, 180 
glutaraldehyde was reacted in aqueous solutions with papain to form a water-insoluble product 181 
with enzymatic activity after activation by reducing agents. A rapid reaction of glutaraldehyde 182 
with the essential sulfhydryl of papain was not involved in the reaction since after activation the 183 
insoluble enzyme retained esterolytic and proteolytic activity.48  184 
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 In another example, a purified preparation of extracellular alkaline proteinase of 185 
Trichoderma koningii was insolubilized by intermolecular crosslinking with glutaraldehyde.49 186 
The optimum operational temperature of the insolubilized enzyme increased by 20 ºC. The 187 
immobilized enzyme was also relatively more stable and activity was less depended on the 188 
presence of ions or detergents than the soluble enzyme. More surprisingly, an enhanced affinity 189 
to casein, hemoglobin and bovine serum albumin was found, although with a lower V max 190 
values. 191 
Intermolecular cross-linking of the protease stem bromelain with 0.25 and 192 
1.25% glutaraldehyde  results in the formation of a large molecular mass, multimeric and 193 
soluble aggregate having comparable activity to the unmodified bromelain. Both 0.25 and 194 
1.25% glutaraldehyde cross-linked bromelain preparations were more stable against urea, 195 
guanidine hydrochloride and temperature-induced inactivation, and exhibited slightly better 196 
storage stability compared to the unmodified protease. Such a high molecular weight, soluble, 197 
active and stable preparation may be useful in industry, i.e. in the textile industry for improving 198 
the properties of a fabric without loss of fabric strength and shape.50  199 
 On the other hand, glutaraldehyde is the intermolecular crosslinker of some of the 200 
recent carrier-free immobilization protocols, such as crosslinked enzyme crystals (CLECs)51,52 201 
(Figure 5) or aggregates (CLEAs) (Figure 6).53-56 While using a conventional homo-bi-202 
functional reagent the ideal strategy seems to modify around 50% of the reactive groups of the 203 
protein to maximize the possibility of crosslinking, the chemistry of glutaraldehyde causes this 204 
option not to be the optimal one, as amino/glutaraldehyde moieties reacts better with other 205 
amino/glutaraldehyde groups than one amino group.33 Moreover, 206 
amino/glutaraldehyde/glutaraldehyde did not react easily with other amino/ (glutaraldehyde)2 207 
groups, making it inconvenient to excessively modify the proteins. Thus, to reach protein 208 
crosslinking using glutaraldehyde, it seems adequate to use moderate concentrations of 209 
glutaraldehyde, high enough to ensure the activation of most amino groups with one molecule of 210 
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glutaraldehyde, but not too high so as not to reach activations with two molecules of 211 
glutaraldehyde per amino group (e.g., 0.1-1% (v/v) glutaraldehyde at pH 7 for 1 hour).36 Milder 212 
activation of the amino groups of the enzyme may produce a milder crosslinking. However, in 213 
some instances it may be necessary to use suboptimal crosslinking conditions if the protein is 214 
especially sensible to glutaraldehyde modifications. In certain cases, as if the enzyme has a Lys 215 
group in its catalytic site (e.g., some aldolases), glutaraldehyde must be discarded and other 216 
crosslinking reagent should be used, such as aldehyde dextran.57  217 
 To achieve a proper crosslinking in this kind of immobilization strategies may be a 218 
problem, mainly if the protein has not many Lys on its surface (Figure 7). This may make the 219 
formation of large aggregates difficult and enable the release of enzyme molecules (individual 220 
molecules or small aggregates) from the solid. In some cases, it is even not possible to get a 221 
solid in aqueous medium. Using CLEAs some solutions have been offered to overcome this 222 
situation. Taking advantage of the fact that the enzyme did not need to be pure to prepare 223 
CLEAs, the co-precipitation of the target enzyme with inert proteins having a high density of 224 
superficial Lys groups (e,g, bovine serum albumin)58-63 or with polymers having many amino 225 
groups (e.g., polyethylenimine)64-67 has been proposed (Figure 8). Both strategies permit the 226 
formation of physically stable CLEAs, but they also produce a decrease in the volumetric 227 
loading of the target enzyme, as part of the volume will be occupied by the inert protein or the 228 
polymer. As an alternative, a strategy based on the use of chemically aminated enzymes with 229 
their protein surface enriched on reactive groups has been proposed (Figure 9).68 This way, it is 230 
not necessary to mix the target protein with any other molecule or polymer and the volumetric 231 
loading of the CLEA is similar to that of proteins that may be directly used to prepare CLEAs. 232 
 233 
3.2. Glutaraldehyde as intramolecular crosslinker of proteins 234 
 The introduction of intramolecular crosslinkings in an enzyme structure is one of the 235 
most widely used techniques to increase enzyme stability, using genetic or chemical 236 
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routes.24,69,70 If the crosslinking agent is short enough, the relative mobility of one group relative 237 
to the other crosslinked group should be minimized.71 Furthermore, if the researcher is able to 238 
introduce several crosslinkings on the enzyme surface, the final result should be a global 239 
rigidification of the overall structure of the enzyme (Figure 10). 240 
However, to introduce several intramolecular crosslinkings in a protein molecule and to 241 
get a significant stabilization effect is not a simple task, as many problems may rise. We will 242 
detail some of the most relevant ones. 243 
- Distance between reactive groups in the protein. The crosslinking formation requires the 244 
existence of at least two reactive moieties in the protein surface at the adequate distance.72,73 If 245 
there are no groups in the range of distances covered by the crosslinker, crosslinking will not be 246 
possible. This may be solved if the researcher somehow increases the number of reactive groups 247 
on the protein surface, e.g. via amination (Figure 11). Site-directed mutagenesis, changing an 248 
aminoacid of the protein by Lys next to other Lys or the terminal amino group, may permit to 249 
increase the prospects of crosslinking just in a desired place (e.g., an unstable area of the 250 
protein). However, although the site directed introduction of Cys residues has been used to 251 
establish disulfide bonds in a protein,74-76 these reviewers have been unable to find the use of 252 
introduce Lys to improve the chemical crosslinking with glutaraldehyde, only to improve the 253 
multipoint covalent attachment via immobilization.77,78 Another possibility is the chemical 254 
amination of the enzyme with ethylenediamine via activation of the carboxylic groups of the 255 
protein with carbodiimide.79,80 This strategy implies the general modification of the enzyme 256 
surface, but the number of reactive groups may be increased by a factor between 2 and 5, 257 
augmenting the possibilities that several groups in the protein surface may be at an adequate 258 
crosslinking distance. This strategy has been utilized to introduce intramolecular crosslinking in 259 
immobilized penicillin G acylase, with stabilization factor of 30-50, depending on the 260 
crosslinking conditions and inactivation cause.33  261 
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- Competition between one-point chemical modification and crosslinking. The first one-point 262 
chemical modification involves a soluble reactive that must modify a group placed in the surface 263 
of a protein. In principle, this one-point modification may be very rapid. However, the 264 
crosslinking reaction involves the correct alignment of two groups located on a moderately rigid 265 
surface, such as that of an enzyme. Using other homo-bifunctional crosslinkers, this competition 266 
may produce serious hindrances to the promotion of an intense crosslinking in the enzyme 267 
surface, using glutaraldehyde, as stated above, there is not a real competition between one-point 268 
modification and crosslinking, as the best solution is an activation of all amines in the protein 269 
with just one glutaraldehyde group. However, there is no guarantee that the modified amino 270 
groups participate in crosslinking. In the best scenario, the final effect of the glutaraldehyde 271 
treatment will be a mixture of crosslinking and chemical modification. The first one should 272 
produce a rigidification of the enzyme surface; the second may have unpredictable effects on the 273 
enzyme features. Some times these effects may be very negative, even overcoming the positive 274 
effects of the crosslinking bridges. Some times, it may be very positive, increasing enzyme 275 
stability even without the formation of any crosslinking.81,82 This effect of the one-point 276 
chemical modification needs to be considered when explaining the effects of the glutaraldehyde 277 
treatment on the stability of a particular enzyme. 278 
- Competition between inter and intra molecular crosslinking. Another possibility is the 279 
competition between intra and intermolecular crosslinking. In fact, using free enzyme, to just 280 
have the desired intramolecular crosslinking may be nearly impossible, as inter molecular 281 
crosslinking is a faster reaction. Although this may also produce enzyme stabilization (see 282 
above), it may complicate the understanding of the results, and also make reproducibility 283 
complex, because the intermolecular crosslinking will depend on the protein concentration, kind 284 
and percentage of contaminant proteins, etc. The use of simple analytical techniques applied to 285 
glutaraldehyde treated samples after reduction with borohydride, such as SDS-PAGE, may 286 
permit to visualize the presence and extension of the intermolecular crosslinking.  287 
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 Even when using immobilized enzymes, to fully prevent enzyme crosslinking may be 288 
hard. Using porous supports, if the immobilization rate is much higher than the diffusion rate, 289 
the enzymes may be packed so near each other that the enzyme molecules may be crosslinked 290 
with each other even using short reagents like glutaraldehyde (Figure 12). If the immobilization 291 
rate is slow enough, the distance between enzyme molecules may be enough to almost fully 292 
prevent enzyme intermolecular crosslinking.83 Recently, by changing the immobilization 293 
conditions, a lipase has been immobilized on octyl agarose and treated with glutaraldehyde.84 294 
Under one immobilization condition, immobilization was quite slow (in presence of ethanol) 295 
and intermolecular crosslinking was almost negligible and it was possible to analyze the effect 296 
of intramolecular modifications. Under another condition, immobilization rate was vey high and 297 
the enzyme molecules were so near that both modifications could be achieved. The comparison 298 
between both derivatives (one having only intramolecular modifications, the other having both 299 
intramolecular and intermolecular modifications) permitted to determine the positive effects of 300 
the intermolecular crosslinking in the enzyme stability. 301 
 302 
3.3. Crosslinking of multimeric enzymes. 303 
 Many enzymes are formed by several subunits, which are in association/dissociation 304 
equilibrium, usually being the associated form the most active and stable.85-87 In other cases, 305 
some cascade reactions may require the joint action of several different enzymes that require 306 
their being associated.88-90 If the researcher is able to crosslink these structures, the system will 307 
work in a more adequate fashion. However, the difficulties commented for the intramolecular 308 
crosslinking remain valid here, even with one additional key point: the reactive groups at the 309 
crosslinking distance need to be placed in different enzyme subunits (Figure 13).23 This is why 310 
crosslinking of these structures may be achieved in a better way using polymers, as they should 311 
not confer an intense structural rigidity, but may be useful to keep together the different enzyme 312 
subunits or maintain the multi enzymatic complex assembled (e.g., dextran aldehyde,91 313 
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polyehtylenimine92,93). Nevertheless, glutaraldehyde has been used in certain cases to stabilize, 314 
even though only in a small percentage of the total enzyme structures, the subunit-subunit 315 
interactions. For example, the crosslinking of the hetero-oligomeric glucose dehydrogenase from 316 
a moderate thermophilic bacterium, SM4, using glutaraldehyde as crosslinking reagent has been 317 
reported.94 The treatment permitted glucose dehydrogenase to gain high thermal stability 318 
without loss of its catalytic activity and thus increase the activity of the enzyme at high 319 
temperature. The authors concluded that by chemical cross-linking of the subunits, the 320 
dissociation of alpha and beta subunits was prevented. Consequently, its quaternary structure 321 
was stabilized, and thus the thermal stability of the glucose dehydrogenase was enhanced. Also, 322 
D-Lactate dehydrogenase  from Limulus polyphemus is a homodimer which is composed of 323 
identical subunits that has been crosslinked with glutaraldehyde to show a relation of 324 
reactivation with reassociation of the dimer.95 325 
 In another paper, primase/helicase produced by bacteriophage T7 that can form both 326 
hexamers and heptamers. These oligomers were stabilized via cross-linking with glutaraldehyde 327 
and purified.96 The authors detected how the percentage of each oligomeric form could be 328 
altered by the presence of either dTTP or β,γ-methylene. Heptamers are unable to efficiently 329 
bind either single-stranded DNA or double-stranded DNA, thus the authors postulated that a 330 
switch between heptamer to hexamer may provide a ring-opening mechanism for the single-331 
stranded DNA binding pathway.  332 
 NTPDase1 and NTPDase2 enzymes from rats were expressed in Xenopus laevis 333 
oocytes and their quarternary structure was analyzed.97 The treatment with glutaraldehyde 334 
permitted to detect that native NTPD-ase1 and NTPD-ase2 occur in oligomeric form.  Dynamic 335 
alterations in oligomeric state may induce changes in substrate preference and thus influence the 336 
pattern of in situ extracellular nucleotide degradation. 337 
 In some instances, glutaraldehyde may have an indirect use to stabilize a multimeric 338 
enzyme, by crosslinking a polymer to the enzyme surface avoiding the polymer release. The 339 
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coating of the surface of multimeric enzymes with a poly-ionic polymer that may 340 
simultaneously interact with several enzyme subunits, preventing enzyme dissociation has 341 
proved to prevent enzyme subunit dissociation if the polymer can become adsorbed on the 342 
enzyme (Figure 14).93 This strategy has been recently utilized to stabilize the enzyme glutamate 343 
dehydrogenase from Thermus thermophilus and formate dehydrogenase  from Pseudomonas sp., 344 
using polyethyleneimine as the “crosslinking” polymer. Both enzymes were inactivated by 345 
dissociation at acidic pH value, and the coating of their surface with polyethyleneimine 346 
prevented this (Figure 14). However, the reversible nature of the polymer adsorption permitted 347 
the polymer to become desorbed under certain conditions (e.g., high ionic strength, drastic pH 348 
value), and the protective effect of the polymer coating was lost. This problem was solved by a 349 
further treatment with glutaraldehyde, crosslinking the enzyme and the polymer: the new 350 
composite was fully stable under enzyme dissociation conditions. This composite could be used 351 
in soluble form, or ionically exchanged on a cation exchanger.93 When a similar strategy was 352 
applied to the hexameric glutamate dehydrogenase from E. coli, the polymer protection was 353 
successful, but the enzyme was rapidly inactivated by incubation with glutaraldehyde.92 Thus, 354 
this strategy not only requires that the polyethyleneimine may stabilize the multimeric structure 355 
of the enzyme without inactivating it, but also requires that the enzyme was resistant to the 356 
treatment with glutaraldehyde. 357 
 358 
4. Intermolecular crosslinking of immobilized proteins via reversible immobilization using 359 
supports unreactive towards glutaraldehyde 360 
 Enzyme immobilization by physical adsorption (using ion exchange, immobilized 361 
chelates or hydrophobic adsorption) is the simplest protocol to immobilize enzymes, does not 362 
require enzyme nor support treatment, immobilization is rapid, and the support does not require 363 
special storage conditions.14 However, this enzyme immobilization strategy has two 364 
disadvantages. The first one, the enzyme may be released from the support under certain 365 
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experimental conditions.98,99 Using ion exchangers, this may occur when changing the pH value 366 
or increasing the ionic strength. Using hydrophobic adsorption, if the reaction requires the 367 
presence of co-solvents or detergents the enzyme may be released to the medium. The second 368 
problem is that physical adsorption may have no positive effects on enzyme stability, even as the 369 
support retains its capacity to interact with the enzyme, the immobilization may produce a 370 
certain destabilization of the enzyme.14   371 
Thus, to prevent enzyme desorption and improve enzyme stability, it is relatively 372 
common to find reports where the researcher, after enzyme reversible immobilization, treats the 373 
immobilized enzyme with glutaraldehyde. In most cases, a certain enzyme stabilization is 374 
observed and enzyme desorption is at least partially avoided under conditions where previously 375 
all the immobilized enzyme became desorbed (Figure 12). Furthermore, this occurs using 376 
supports with which the glutaraldehyde can not react, thus the enzyme cannot become 377 
immobilized on the support. This is the case of supports having aliphatic acyl moieties or 378 
quaternary amine groups as active groups on the support; glutaraldehyde hardly can react with 379 
these groups in the support.  380 
 To explain these results, we should go back to point 3.2 of this review. Immobilization 381 
via physical adsorption is usually much faster than enzyme diffusion inside the support pores 382 
and in most cases the treatments of the biocatalyst involving glutaraldehyde described in the 383 
literature are performed using fully protein loaded biocatalysts. Under these conditions, the 384 
enzymes are packed together, so close to each other that the distance is in the range of 385 
glutaraldehyde crosslinking. Furthermore, if two reactive groups are conveniently confronted, 386 
intermolecular crosslinking will occur (Figure12).84 Moreover, intramolecular modifications 387 
(one point or crosslinkings) will also take place, reinforcing in some cases the stabilization 388 
effects. Regarding enzyme release, it now becomes necessary to simultaneously release all 389 
adsorbed enzymes, otherwise the aggregate will remain adsorbed. This makes that the “strength” 390 
of the adsorption increases exponentially with the size of the aggregate, and under conditions 391 
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where individual molecules were fully desorbed, now the enzyme remains fully adsorbed on the 392 
support.84   393 
As in certain cases the reactivity of the support with the glutaraldehyde cannot be fully 394 
discarded due to its unknown nature, the lack of glutaraldehyde reaction with the support may be 395 
verified via different strategies. For example, it is possible to check if we can “preactivate” the 396 
support, to achieve a covalent attachment between the enzyme molecules and the support after 397 
washing the support with an excess of water to eliminate all free glutaraldehyde molecules and 398 
later offering the enzyme. The use of Schiff reactive may also help to verify if some reactive 399 
glutaraldehyde remain bound to the support after the washings. Second, slowing down the 400 
immobilization rate of the enzyme to increase the distance between enzyme molecules, and 401 
checking if the glutaraldehyde treatment still avoids desorption of a significant percentage of the 402 
enzyme molecules. 403 
 One drawback of this strategy is that desorption of very large chemical aggregates may 404 
be fully impossible even under the most drastic conditions, transforming a reversible 405 
immobilization method in an irreversible one. The researcher should carefully evaluate the 406 
convenience of this treatment, considering the stability requirements of the enzyme and the real 407 
risks of enzyme desorption during the use of the biocatalyst versus the possibility of having to 408 
discard the support after enzyme immobilization.14  409 
 This strategy has been used in several examples to prepare crosslinked enzyme 410 
aggregates in an immobilized form, that some authors call CLEAs (see above), but which really 411 
are an altogether different thing. Hierarchically ordered mesocellular mesoporous carbon was 412 
used as a host for enzyme immobilization.100 To improve the retention of enzymes, the adsorbed 413 
enzymes were cross-linked using glutaraldehyde. The resulting preparation showed a significant 414 
stabilization with high enzyme loadings. For example, 0.5 g chymotrypsin could be loaded in 1 415 
g of silica with no activity decrease observed with rigorous shaking over one month. In contrast, 416 
adsorbed chymotrypsin without any crosslinking treatment resulted in a lower loading, which 417 
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further decreased due to continuous leaching of adsorbed chymotrypsin under shaking. The 418 
activity of crosslinked enzyme aggregates was 10 times higher than that of the adsorbed 419 
chymotrypsin.. 420 
 In two papers, both α-chymotrypsin and a lipase were immobilized in SBA-15 421 
mesoporous silica by crosslinking adsorbed enzymes to give the so-called one-dimensional 422 
crosslinked enzyme aggregates.101,102 This simple approach resulted in one-dimensional 423 
crosslinked enzyme aggregates in the linear pore channels of SBA-15, which was very effective 424 
in preventing the enzyme leaching and consequently improving the enzyme stability.  425 
 In another research effort, meso-structured onion-like silica was produced with a 200-426 
300 nm sized primary meso-structured onion building unit, with each onion unit having highly 427 
curved mesopores of 10 nm diameter in a multishell structure.103 Nanoscale enzyme reactors in 428 
these supports were prepared via a two-step process of enzyme adsorption and subsequent 429 
enzyme cross-linking with glutaraldehyde, which effectively prevents the leaching of cross-430 
linked enzyme aggregates from highly curved mesopores. This improved the enzyme stability as 431 
well as the enzyme loading.  432 
 In another example, β-glucosidase was immobilized onto mesocellular silica foams 433 
and later crosslinked with glutaraldehyde.104 This resulted in the formation of crosslinked 434 
enzyme aggregates of nanometer scale. The final catalyst was more stable and presented a lower 435 
Km than that of its free counterpart.  436 
 Other authors really produced CLEAs inside the pores of supports, taking advantage of 437 
the increase in size of the enzyme when an aggregate was formed. However, they are neither 438 
real CLEAs, as the enzyme is not previously precipitated (Figure 15). This is the case of the 439 
examples described by Prof Hartman´s group. Using chloroperoxidase, they showed that the 440 
formation of cross-linked chloroperoxidase aggregates in the pores of mesocellular foam 441 
materials results in active biocatalysts that are more resistant to leaching than the conventional 442 
catalyst prepared by physisorption of chloroperoxidase. Small-angle neutron scattering  443 
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experiments clearly confirm that the chloroperoxidase -CLEAs are located in the pores of the 444 
mesocellular foams.105 Later, they extended the studies to glucose oxidase. The formation of 445 
cross-linked enzyme aggregates of glucose oxidase in the pores of mesocellular foams was 446 
obtained. The enzymes can enter the ultra-large cavities connected through the smaller windows, 447 
where their agglomeration and cross-linking with glutaraldehyde will take place. After cross-448 
linking, the diameter of the aggregates is larger than the diameter of the pore entrance and, thus, 449 
the enzymes are trapped in the pores of the support.106 Finally, glutaraldehyde cross-linked 450 
enzyme aggregates of chloroperoxidase and glucose oxidase were grown in large-pore 451 
mesocellular foams, improving operational stability in the oxidation of indol.107  452 
 453 
5. Crosslinking of supports bearing primary amino groups and ionically exchanged 454 
proteins 455 
 In this new example of use of glutaraldehyde to immobilize enzymes in preexisting 456 
supports, as in the case explained above, the treatment with glutaraldehyde is performed after 457 
the enzyme is adsorbed in the support, in this case via ion exchange. However, this is a fully 458 
different case from the one described above. Now, the researcher knows that the support has 459 
primary amino groups, and that, therefore, it is likely to modify the support with glutaraldehyde, 460 
and finally obtain enzyme-support covalent bonds.108 Thus, in this case, the enzyme may 461 
experience three different kinds of modifications caused by glutaraldehyde (Figure 16): 462 
1-  Intramolecular modifications (one point modifications or crosslinking, see above). 463 
2- Interprotein crosslinking. If the ion exchange immobilization has been rapid enough, 464 
the enzymes will be very near each other and it is likely to have enzyme-enzyme crosslinking 465 
(see above). 466 
 3- Support-enzyme reaction. The support and the enzyme molecules may react with each 467 
other. In fact, if the treatment with glutaraldehyde is performed in a way that enables the 468 
modification of each reactive group in the support and the enzyme with one glutaraldehyde 469
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molecule, we will have the situation where the highest prospects of enzyme support reaction 470 
may occur. And this reaction will take place in a relative wide range of pH value, as the reaction 471 
will occur between amino/glutaraldehyde moieties; although considering the stability of the 472 
groups and its reactivity, some reports suggest that pH values around 8.5 may be the most 473 
adequate.33 That way, the support will behave as a large multi-crosslinking reagent, fixing the 474 
positions of all the protein groups involved in the reaction with the support, whose relative 475 
position must remain unaltered under any distorting condition, promoting an increase of the 476 
overall enzyme structure, which becomes more intense when a more intense multipoint covalent 477 
attachment is achieved.17,109-111  478 
 Thus, this strategy has some positive points, as the good reactivity of the amino 479 
glutaraldehyde moieties with similar groups in a relatively wide range of pHs, that include 480 
neutral pH, the fact that the glutaraldehyde treatment is performed on a previously immobilized 481 
enzyme, and the possibilities of having some positive inter or intra-modifications. This last point 482 
is also the drawback of the strategy, as the enzyme should be fully modified, not only in the 483 
groups involved in the immobilization, and in some cases these modifications may be negative 484 
for enzyme stability or activity. However, in many instances when there is a comparison 485 
between immobilization on preactivated supports (see below) or treatment with glutaraldehyde 486 
after enzyme in exchange, stabilization improves using this strategy.108,112,113  487 
 In other many cases, a comparison was not performed but results using the treatment 488 
of previously adsorbed enzymes were very positive regarding stabilization and prevention of 489 
enzyme leakage.114-119  490 
 The treatment of lipases adsorbed on anion exchanger supports has been in some cases 491 
used to modulate enzyme properties. Thus, the open form of some lipases was fixed by 492 
glutaraldehyde treatment of adsorbed lipases in the presence of detergents.120 In other cases, the 493 
random chemical modification was enabled to modulate the lipase selectivity or specificity.121   494 
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 This strategy may be only used when the support is able to immobilize the protein via 495 
ionic exchange. That means that the support should present a high enough number of ionic 496 
groups to permit the adsorption of the enzyme on the support. Moreover, the enzyme should 497 
have the capacity to become adsorbed to anion exchangers. Considering that this is a multipoint 498 
process (several ion bridges need to be produced to fix the enzyme to the support),122-124 the 499 
strategy presents the problem that the support should never be physically inert. Furthermore, the 500 
inertness of the support surface may be in many instances a desired feature of the support, to 501 
prevent uncontrolled support-enzyme interactions that may affect enzyme stability (sometimes 502 
in a positive sense, but in another may have a negative impact in the enzyme stability).14,125 503 
Another negative point to be considered is the possibility of reactivating the enzyme after 504 
inactivation, the folding-unfolding strategy may not work if the unfolded enzyme may interact 505 
with the support.14  506 
 Moreover, the strategy does not offer a large versatility. It may be possible that the 507 
immobilization via ionic exchange under different conditions of pH and ionic strength may 508 
involve different areas, but that is the only way of altering the enzyme orientation regarding the 509 
support.126-128 The immobilization of an enzyme via different areas may be interesting to reach 510 
optimum stabilization (involving the most labile area of the protein in the immobilization)22,129-511 
132 or to tune the enzyme catalytic properties (selectivity, specificity, activity).17  512 
 513 
6. Activation of supports with glutaraldehyde 514 
 In this last case, the support is pre-activated with glutaraldehyde. Following the results 515 
from Monsan, the optimal activation regarding the chemical reactivity of the support should be 516 
two molecules of glutaraldehyde per amino group in the support (obtained, e.g., by incubating 517 
the support in 1 M glutaraldehyde at pH 7 by 12-16 h).37  It is very likely the most widespread 518 
form of using glutaraldehyde to immobilize enzymes (see for example133-141) and one of the first 519 
papers concerning the use of glutaraldehyde to prepare immobilize enzymes may be found in .142  520 
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Compared to the strategy described above, this method has some advantages and 521 
drawbacks. As a drawback, we can consider the higher difficulty on having an intense 522 
multipoint covalent attachment, as now the reaction is between 523 
amino/glutaraldehyde/glutaraldehyde moieties and the ε amino groups of the Lys residues (and 524 
the terminal amino group). The Lys groups have a pK of 10.7, and the stability of the 525 
glutaraldehyde groups in the support is not good at alkaline pH value while at neutral pH value 526 
the reactivity of the amino groups is relatively low. At neutral pH value, the most reactive amino 527 
group is the terminal one, with a pK value between 7 and 8, being much more reactive that the 528 
addition of the reactivities of all Lys external groups.143 However, it should be considered that 529 
after the first immobilization, if some nucleophiles of the protein are in the area exposed to the 530 
support, the high apparent concentration of the different groups may permit the establishment of 531 
some new covalent enzyme-support bonds.144 Moreover, the preactivated support may not be 532 
stored for a long time under wet conditions due to the relatively low stability of the groups. 533 
 The first advantage compared to the case described in Section 5, is that now only the 534 
groups involved in the covalent immobilization are modified by glutaraldehyde. Moreover, the 535 
support may immobilize enzymes even if they are very poorly activated, because the enzyme is 536 
covalently fixed to the support just with one point as the glutaraldehyde-protein bonds are 537 
stable. Thus, using very lowly activated amino supports (e.g., 1 reactive group under each 538 
projected area of the protein) immobilization using glutaraldehyde activated supports will be 539 
directly performed by a covalent reaction by the most reactive amino group on the enzyme (very 540 
likely the amino group of the enzyme if immobilization is performed at neutral pH value).143 541 
However, immobilization will be very slow due to the low activation of the support, and will 542 
offer no chance of reaching an intense multipoint covalent attachment.14  543 
 On the other hand, using highly activated supports; the features of the spacer arm 544 
(amino/glutaraldehyde/glutaraldehyde) convert the supports in a heterofunctional support. The 545 
term “heterofunctional support” may be applied to supports that present several functionalities 546 
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on its surface that are able to interact with different groups of an enzyme, and these interactions 547 
may be different under different conditions (Figure 17).145,146 548 
 Immobilization of enzymes on a heterofunctional support may be more versatile. If the 549 
researcher is able to benefit from this fact it may be an advantage, but if this fact is not 550 
considered, the understanding of the results may be really complex. The use of heterofunctional 551 
supports to immobilize proteins has been recently discussed in the literature.147 In this review we 552 
will focus on glutaraldehyde activated supports. 553 
 The multifunctionality of the supports having a high surface density of amino groups and 554 
activated with glutaraldehyde is a direct consequence of the way they are prepared. Their 555 
preparation requires the modification of supports bearing primary amino groups with two 556 
glutaraldehyde molecules, if the optimal protocol is followed.28,36,37 The final result is a support 557 
having spacer arms bearing one or two amino groups (cationic groups that may function as 558 
anion exchangers), a fairly hydrophobic moiety formed by the glutaraldehyde dimer and the 559 
covalent reactive group.  560 
In this way, a support highly activated with glutaraldehyde may give three different kinds 561 
of interactions with a protein: hydrophobic, anionic exchange and covalent (Figure 18).84  562 
Biomacromolecules are only immobilized on supports via ionic exchange or hydrophobic 563 
interactions when several enzyme-support interactions may be established, being the one point 564 
interaction insufficient to immobilize a protein.128 Thus, these interactions will only have a real 565 
impact on enzyme immobilization when using supports bearing several amino-(glutaraldehyde)n 566 
moieties under each enzyme molecule (Figure 18). 148-153 Thus, using highly activated 567 
glutaraldehyde supports, the three immobilization causes may be able to immobilize a protein 568 
molecule. If the researcher is aware of this fact, it is possible to permit that one or the other 569 
immobilization cause may be the dominant one, by playing with the experimental conditions.38  570 
This permits to immobilize enzymes following different orientations regarding the support 571 
surface. If there is a very small amount of groups on the support, (e.g. just one spacer arm per 572 
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projected area of the enzyme), this multi-interaction will no longer be possible or will be so 573 
slow, that the only relevant cause of immobilization will be the one point covalent 574 
immobilization, as explained above.143,148-153  575 
This means that even if all enzyme molecules are immobilized (incorporated to the 576 
support) in a very rapid fashion using a highly activated glutaraldehyde support, there is no 577 
guarantee that covalent immobilization of the enzyme on the support has taken place. In fact, the 578 
immobilization may be very strong, and the enzyme may remain immobilized under conditions 579 
where the enzyme may be fully released from the mother amino support, and still the enzyme 580 
molecules may be just adsorbed, as now the adsorption may be mixed, ionic/hydrophobic.84 To 581 
ensure that covalent immobilization has taken place, the enzyme should remain immobilized 582 
under conditions where both ionic and hydrophobic interactions may be broken (e.g., using 583 
cationic detergents, using guanidine, increasing the ionic strength in the presence of non-ionic 584 
detergents).84  585 
Using highly activated supports, it has been shown that in most cases an ionic exchange 586 
with the amino groups in the support is the first step in the immobilization of most 587 
enzymes.22,38,84,154-156  588 
One effect of this first ionic adsorption is that, even though glutaraldehyde is able to 589 
immobilize enzymes via just one attachment due to the stability of the bond formed, the 590 
activation degree of the support has an exponential effect on the immobilization reaction rate of 591 
proteins, not the expected linear effect using reactive groups in the support able to immobilize 592 
the proteins via just one point.143 This is because the researcher is measuring the rate of ionic 593 
exchange of the enzyme on the support, which requires the establishment of several enzyme-594 
support interactions, and thus it is exponentially dependent on the surface density of amino 595 
groups on the support although the covalent reaction should be of order 1.38,148-153 This 596 
immobilization mechanism is much faster that the direct covalent attachment via 597 
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glutaraldehyde-enzyme covalent reaction, being this way the first cause of immobilization for 598 
most enzyme molecules. 599 
This multifunctionality of the glutaraldehyde supports is an advantage in certain cases. 600 
The rapid ionic exchange of the enzyme on the support keeps the enzyme from being in soluble 601 
form before being covalently immobilized (thus avoiding some inactivation causes, such as 602 
interaction with interfaces or autolysis).16,17 If enzyme immobilization via ion exchange has a 603 
positive effect on enzyme stability, enzyme inactivation by distortion will also be slowed down. 604 
However, the main advantage of the multifunctionality of glutaraldehyde is that we can 605 
alter the enzyme orientation on the support by changing the immobilization conditions, favoring 606 
one mechanism or another as the first immobilization cause (Figure 18). 607 
If the researcher wishes to have a first hydrophobic adsorption, this can be achieved 608 
using a high enough ionic strength. The glutaraldehyde dimer is not very hydrophobic, but may 609 
be hydrophobic enough if the surface density of the groups in the support is high enough. Using 610 
very high ionic strength, the ionic exchange will be rolled out, and the areas of the protein with 611 
high concentration of external hydrophobic groups may be involved in the first enzyme 612 
adsorption and delimit the area where the reactive groups of the enzyme which will react with 613 
the support should be located. After enzyme hydrophobic adsorption, the reactive groups of the 614 
enzyme near the support surface may produce some covalent reactions. However, this will be 615 
produced after enzyme immobilization, and there is no guarantee that the enzyme will finally 616 
have any covalent attachment with the support (e.g., if there are no reactive groups on the 617 
enzyme surface in that area).  618 
 The second possibility is to permit ionic exchange of the enzyme prior to covalent 619 
immobilization. Using most enzymes, the use of low ionic strength is enough to reach this 620 
situation (an ionic strength that permits ionic exchange of the proteins on the non-activated 621 
glutaraldehyde amino support).38,84 In this case, the enzyme will be first immobilized on the 622 
support by ionic exchange and this area will be the one where nucleophiles capable of reacting 623 
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with the glutaraldehyde moieties should be located. Ionic exchange may also involve different 624 
enzyme regions depending on the experimental conditions and activation degree of the support. 625 
Ionic exchange at different pH values may in certain enzymes change the area where the highest 626 
concentration of available anionic charged groups may be found. Furthermore, the ionic strength 627 
may determine the area involved because the higher the ionic strength, the more restrictive the 628 
immobilization becomes (requiring more enzyme support-interactions).126,127  629 
Finally, it is possible to immobilize the enzyme via a direct first covalent attachment, 630 
involving the most reactive exposed group of the enzyme (usually the terminal amino group). 631 
Using most enzymes, the moderate ionic strength used to prevent ionic exchange (100-250 mM 632 
of NaCl) is not enough to force the hydrophobic adsorption of the protein on the support (that is 633 
not very hydrophobic) and a direct covalent immobilization may be the first cause for the 634 
enzyme immobilization.38,84 635 
 Lipases are a special case of enzymes that permit a new alternative to the 636 
immobilization on glutaraldehyde activated supports. This has special interest as they are 637 
perhaps the most used enzymes in industry and academic studies due to their broad range of 638 
substrates and reactions, accompanied of a high enantio- and regio- selectivity or specificity, 639 
together to good stability in different reaction medium and wide availability.157-159  640 
Lipases are complex enzymes that usually have two conformations, a closed one where 641 
the active center is secluded from the medium by a polypeptide chain (lid or flap), and an open 642 
form, where the lid is displaced and the active center of the lipase is exposed to the medium 643 
(Figure 19).160 This open form presents a very large hydrophobic area exposed to the medium, 644 
formed by the hydrophobic residues around the active center of the lipase and the hydrophobic 645 
groups in the internal face of the lid.161 The exposition to a hydrophilic medium (e.g., an 646 
aqueous buffer) of this large hydrophobic area is unfavorable, thus the enzyme in aqueous 647 
homogeneous media will be mainly in the closed form. However, this open form is readily 648 
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adsorbed on the hydrophobic surface of the oil drops even at very low ionic strength (interfacial 649 
activation) (Figure 19)..162,163   650 
It has been shown that lipases may become adsorbed via a similar mechanism on any 651 
other hydrophobic surface (hydrophobic supports, hydrophobic proteins, other “open” lipases). 652 
164-166 Thus, the use of hydrophobic supports to immobilize lipases at low ionic strength has been 653 
suggested as a simple way to obtain the open and stabilized form of the immobilized lipases.167 654 
Although this interfacial activation is the specific feature of lipases, the lid may be quite 655 
different from one lipase to another, e.g., lipase B from Candida antarctica has a very small lid 656 
that can not fully seclude the active center from the medium,168 while the lipase from Bacillus 657 
thermocatenulatus has a double lid and a very complex movement governing its activation.169 658 
This immobilization is based on the fact that the hydrophobic support mimics the natural 659 
substrate of lipases. And highly activated glutaraldehyde activated supports offers a fairly 660 
hydrophobic surface to this interfacial activation of lipases. 661 
In fact, it has been shown that using lipases, it is at least possible to immobilize the 662 
enzyme via 4 different mechanisms on highly activated glutaraldehyde supports.84  663 
 Thus, the control of the immobilization on these supports using lipases is more 664 
complex, but the support offers a new immobilization orientation. 665 
 Due to the tendency of the open form of the lipases to become adsorbed versus 666 
hydrophobic interfaces,164,170,171 if the immobilization is just performed at low ionic strength, the 667 
enzyme will be immobilized by both immobilization mechanisms: interfacial activation and 668 
ionic exchange (Figure 20).84  Depending on the enzyme, the support and the immobilization 669 
conditions, one or the other immobilization cause may be predominant, but most likely the other 670 
cause will always be present in a major or minor percentage. This mixture of lipase orientations 671 
is not the ideal situation if the researcher wishes to tune lipase properties via immobilization and 672 
may also make difficult to understand the results. In fact, this is the usual situation that we may 673 
find in the literature.  674 
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 This situation may be avoided by using non-ionic detergents, which prevent the 675 
interfacial activation of the lipase versus a hydrophobic support (Figure 21). 164 Performing the 676 
immobilization in the presence of Triton X-100 at low ionic strength, lipases are mainly 677 
immobilized on the glutaraldehyde supports via a first ionic exchange.84  Using moderate ionic 678 
strength, the enzyme immobilization will mainly proceed via interfacial activation (Figure 22). 679 
 The use of very high ionic strength will cause the lipase to adopt mainly the closed 680 
form, permitting as a first immobilization step the conventional hydrophobic adsorption via 681 
hydrophobic groups located on the lipase surface (Figure 23). It has been reported that 682 
interfacial activation of lipases on hydrophobic supports is slowed at high ionic strength.164 That 683 
way, using an ionic strength just high enough able to prevent the ionic exchange of the lipase, 684 
lipases will become immobilized on the support first via a rapid interfacial activation on the 685 
support, which is much faster than the direct covalent attachment.84  686 
 The only way to ensure that the first step in the immobilization of a lipase in these 687 
supports is a covalent attachment is to simultaneously prevent ionic exchange and interfacial 688 
activation. This may be achieved using simultaneously moderately high ionic strength and 689 
detergents, or ionic detergents (Figure 24).84  690 
 Whatever the enzyme used, if we have a situation where the first phenomenon is 691 
covalent immobilization, the surface density of groups in the support will have a first order 692 
effect on the rate of enzyme immobilization.143 If this is not the case (mainly at the highest 693 
support activation degree), another cause may be the responsible for the first enzyme 694 
immobilization.  695 
Thus, it is possible to immobilize enzymes on glutaraldehyde supports via different first 696 
events. This may lead to different orientations of the enzyme on the support, offering different 697 
stabilities.38 In the case of lipases, they also exhibited different catalytic behavior (e.g., 698 
specificity was altered).84 This way, it is possible to have, using the same immobilization 699 
support, enzymes immobilized by different areas, with different numbers of enzyme molecule-700 
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support covalent bonds and different enzyme-support unspecific interactions.147 We should bear 701 
in mind that, due to the proximity between the groups of the support and of the enzyme, 702 
interactions between immobilized enzyme and support will be produced over time even though 703 
they may not be enough to be the only cause for immobilization.144 704 
 In other, more difficult to classify cases, a lipase was immobilized on electrospun and 705 
ethanol-dispersed polystyrene-poly(styrene-co-maleic anhydride) nanofibers in the form of 706 
enzyme precipitate coatings.172 Lipase precipitate coatings were prepared in a three-step process, 707 
consisting of lipase covalent attachment, lipase precipitation, and crosslinking of precipitated 708 
lipases onto the covalently attached lipases via glutaraldehyde treatment. 709 
 A similar approach was used to immobilize β-glucosidase. The enzyme was 710 
immobilized on polymer nanofibers. Then, additional enzyme molecules were crosslinked onto 711 
the covalently attached enzyme molecules via glutaraldehyde treatment.173  712 
 713 
 Conclusions 714 
 Glutaraldehyde, an apparently old fashioned reagent use for a long time in design of 715 
biocatalyst, remains as one of the most interesting tools in enzyme crosslinking and 716 
immobilization (Figure 25).  However, to achieve optimal results, it is necessary to understand 717 
the different reactivities of the amino/glutaraldehyde and amino/glutaraldehyde/glutaraldehyde, 718 
together with the fact that, in immobilization of enzymes on glutaraldehyde pre-activated 719 
supports, it is a heterofunctional support that permits altering the enzyme orientation on the 720 
support surface.  Thus, glutaraldehyde remains one of the most potent and versatile tools in 721 
Enzyme technology, and the new knowledge on its reactivity and possibilities open even new 722 
opportunities for the future. 723 
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FIGURE LEGENDS 1017 
 1018 
FIGURE 1.  Possible structures of glutaraldehyde in aqueous solution. 1019 
FIGURE 2.   Reactions of glutaraldehyde with proteins under acidic or neutral conditions. 1020 
FIGURE 3.  Schiff base (1) and Michael-type (2) reactions of glutaraldehyde with proteins 1021 
under basic conditions 1022 
FIGURE 4.  Immobilization of enzyme via copolymerization with glutaraldehyde. 1023 
FIGURE 5. Preparation of Crosslinked Enzyme Crystals (CLECs). 1024 
FIGURE 6. Preparation of Crosslinked Enzyme Aggretates (CLEAs). 1025 
FIGURE 7. Problems in the crosslinking step during CLEAs preparation using enzymes poor 1026 
in Lys residues. 1027 
FIGURE 8. Preparation of combi-CLEAs using proteins having many Lys residues to 1028 
facilitate the crosslinking step. 1029 
FIGURE 9. Amination of enzymes that are poor in Lys residues to facilitate the crosslinking 1030 
step in CLEA preparation. 1031 
FIGURE 10. Effect of intramolecular crosslinking on the stability of enzymes. 1032 
FIGURE 11. Amination of enzyme surfaces to facilitate the promotion of an intense 1033 
intramolecular crosslinking. 1034 
FIGURE 12. Effect of the immobilization rate on the possibilities of intermolecular 1035 
crosslinking between immobilized enzyme molecules. 1036 
FIGURE 13. Chemical crosslinking of subunits in multimeric enzymes. 1037 
FIGURE 14. Stabilization of polyethyleneimine/enzyme composites via glutaraldehyde 1038 
crosslinking to prevent subunit dissociation. 1039 
FIGURE 15. Production of enzyme chemical aggregates to prevent enzyme leakage on mildy 1040 
adsorbed enzymes. 1041 
FIGURE 16. Crosslinking of enzymes and aminated supports after enzyme ionic adsorption. 1042 
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FIGURE 17. Multifunctional supports. 1043 
FIGURE 18. Effect of the superficial density of glutaraldehyde groups on the possibilities of 1044 
physical adsorption of the enzyme on the support surface. 1045 
FIGURE 19. Interfacial activation of lipases. 1046 
FIGURE 20. Immobilization of lipases at low ionic strength on glutaraldehyde activated 1047 
supports. 1048 
FIGURE 21. Immobilization of lipases at low ionic strength in the presence of a detergent on 1049 
glutaraldehyde activated supports. 1050 
FIGURE 22. Immobilization of lipases at high enough ionic strength to prevent ionic exchange 1051 
on glutaraldehyde activated supports. 1052 
FIGURE 23. Immobilization of lipases at very high ionic strength (more than 1 M) on 1053 
glutaraldehyde activated supports. 1054 
FIGURE 24. Immobilization of lipases at moderate ionic strength and in the presence of 1055 
detergents on glutaraldehyde activated supports. 1056 
FIGURE 25. Glutaraldehyde, a versatile reagent in enzyme biocatalyst design. 1057 
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